PLAU and COVID-19: Our data argue that the analysis of uPA, uPA/PAI-1 complex, and non-complexed PAI-1 should be included in the fibrinolysis status of COVID-19 patients, as they can identify “fibrinolysis-sleeper/shutdown” patients with low D-dimer levels who progress rapidly into the complicated phase.